Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-07

FDA Approved: OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for olopatadine hydrochloride ophthalmic solution from Bausch & Lomb, indicating regulatory approval related to this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (olopatadine hydrochloride ophthalmic solution)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION)